These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10915749)

  • 21. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
    Silverman AL; Piquette DL; Filipiak CL; Neill JS; Bayati N; Gordon SC
    Am J Gastroenterol; 1997 Oct; 92(10):1793-5. PubMed ID: 9382038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
    Yu ML; Dai CY; Lee LP; Hou NJ; Hsieh MY; Huang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    Liver Int; 2006 Dec; 26(10):1187-95. PubMed ID: 17105583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
    Parolin MB; Lacerda MA; Lopes RW
    Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
    Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia.
    Shiffman ML; Hofmann CM; Contos MJ; Luketic VA; Sanyal AJ; Sterling RK; Ferreira-Gonzalez A; Mills AS; Garret C
    Gastroenterology; 1999 Nov; 117(5):1164-72. PubMed ID: 10535880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-evaluation of the serum alanine aminotransferase upper normal limit in chronic hepatitis C patients.
    Yagura M; Tanaka A; Kamitsukasa H; Otsuka H; Kanno S; Aoyama T
    Intern Med; 2010; 49(6):525-8. PubMed ID: 20228585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study.
    Mirza S; Siddiqui AR; Hamid S; Umar M; Bashir S
    BMC Gastroenterol; 2012 Jun; 12():71. PubMed ID: 22697612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.
    El Kassas M; Alboraie M; Mostafa A; Ezzat R; El Tahan A; Afify S; Sweedy A; Kabbash I; Esmat G
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28752960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hepatitis C and normal ALT: considerations for treatment.
    Bacon BR
    Am J Gastroenterol; 2004 Sep; 99(9):1706-7. PubMed ID: 15330906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT.
    Mukherjee S
    Am J Gastroenterol; 2005 Mar; 100(3):727; author reply 727. PubMed ID: 15743377
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis C.
    Atsukawa K; Saito H; Ebinuma H; Morizane T; Takahashi M; Ohishi T; Kumagai N; Tsuchimoto K; Ishii H
    Hepatogastroenterology; 2000; 47(36):1685-90. PubMed ID: 11149032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.
    Uberti-Foppa C; De Bona A; Morsica G; Galli L; Gallotta G; Boeri E; Lazzarin A
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):146-52. PubMed ID: 12794546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should patients with chronic hepatitis C who have normal ALT levels be treated?
    Russo MW; Brown RS
    Curr Gastroenterol Rep; 2001 Feb; 3(1):49-53. PubMed ID: 11177694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
    Oliveira LP; de Jesus RP; Boulhosa RS; Mendes CM; Gnoatto MC; Lemaire DC; Toralles MB; Cavalcante LN; Lyra AC; Lyra LG
    World J Gastroenterol; 2012 May; 18(18):2203-11. PubMed ID: 22611313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis C viral infection in patients with normal serum alanine aminotransferases.
    Di Bisceglie AM
    Am J Med; 1999 Dec; 107(6B):53S-55S. PubMed ID: 10653458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.
    Watkins PB; Dube LM; Walton-Bowen K; Cameron CM; Kasten LE
    Drug Saf; 2007; 30(9):805-15. PubMed ID: 17722971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of chronic hepatitis C by bicyclum, a randomized double-blind placebo controlled trial].
    Yao G; Ji Y; Zhou X; Wang Q; Wu W
    Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):958-60. PubMed ID: 12181088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.